MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1001/jamanetworkopen.2025.11081

Медицинская библиотека · JAMA network open · 2025

Clinical Validation of a Vaginal Cervical Cancer Screening Self-Collection Method for At-Home Use: A Nonrandomized Clinical Trial.

Fitzpatrick Megan B, Behrens Catherine M, Hibler Karl, Parsons Courtney, Kaplan Clair, Orso Ronald, Parker Lamar, Memmel Lisa, Collins Ann, McNicholas Colleen, Crane LaShonda, Hwang Youri, Sutton Elizabeth, Coleman Jenell, Kuroki Lindsay, Harshberger Kimberly, Williams Sigrid, Jennings Ashley, Buccini Frank, Gillis Laura, Novetsky Akiva P, Hawkes David, Saville Marion, Depel Trena, Aviki Emeline, Sheth Sangini S, Conageski Christine

СтатьяКлиническое исследованиеВалидационное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

IMPORTANCE

One-quarter of US women who are at risk for cervical cancer delay screening. Self-collected (SC) cervical screening was recently US Food and Drug Administration (FDA)-approved in the US for use in a health care setting only; an at-home SC option is crucial to address clinic-related barriers to screening.

OBJECTIVE

To clinically validate the use of an SC device that was designed for optimal at-home performance, safety, ease-of-use, and dry storage and transport.

DESIGN, SETTING, AND

PARTICIPANTS

This nonrandomized clinical trial used a prospective method comparison study design. Participants aged 25 to 65 years were recruited from 16 clinical sites in the US including community and academic practices from November 20, 2023, to April 5, 2024. Data analysis was conducted from April to August 2024.

INTERVENTION: Eligible participants collected a sample with the SC method, followed by a clinician-collected (CC) sample. The SC sample was eluted into PreservCyt at the laboratory and both samples were tested on an FDA-approved high risk human papillomavirus (hrHPV) test approved for primary screening. Participants were followed up for safety and completed usability and screening preference surveys.

MAIN OUTCOME AND MEASURES: The primary outcome measures were positive percentage agreement (PPA) and negative percentage agreement for detection of hrHPV between the SC and CC samples. Other study measures included clinical sensitivity for high grade cervical dysplasia and usability.

RESULTS

Of 609 screening-eligible participants, 599 (262 aged 30-39 years [43.7%]; 583 identified as female [97.3%]) had paired SC-CC samples, of which 582 had valid paired samples included in the end point analysis. Among the 582 evaluable paired samples, the PPA between SC compared with paired CC samples for detection of hrHPV was 95.2% (95% CI, 92.1%-97.1%; 278 of 292 participants). The absolute clinical sensitivity for detection of high-grade cervical dysplasia was 95.8% (95% CI, 86.0%-98.8%; 46 of 48 participants), equivalent to the CC (relative sensitivity, 1.00). Nearly all participants (555 of 601 participants [92.3%]) reported that the device instructions were easy or very easy to understand and also that they would choose SC if they knew the results were comparable to CC results (560 of 602 participants [93.0%]).

CONCLUSIONS AND RELEVANCE: In this nonrandomized clinical trial, SC samples collected with the device showed equivalent clinical sensitivity and exceeded the PPA end point for cervical screening. This SC method was found to be easy to use and to be a preferred option with high clinical performance intended for use in an at-home setting.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT06120205.

Для цитирования: Fitzpatrick Megan B, Behrens Catherine M, Hibler Karl, Parsons Courtney, Kaplan Clair, Orso Ronald, Parker Lamar, Memmel Lisa, Collins Ann, McNicholas Colleen, Crane LaShonda, Hwang Youri, Sutton Elizabeth, Coleman Jenell, Kuroki Lindsay, Harshberger Kimberly, Williams Sigrid, Jennings Ashley, Buccini Frank, Gillis Laura, Novetsky Akiva P, Hawkes David, Saville Marion, Depel Trena, Aviki Emeline, Sheth Sangini S, Conageski Christine. Clinical Validation of a Vaginal Cervical Cancer Screening Self-Collection Method for At-Home Use: A Nonrandomized Clinical Trial.. JAMA network open. 2025. DOI: 10.1001/jamanetworkopen.2025.11081.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.